XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · Real-Time Price · USD
0.8502
+0.0001 (0.02%)
Jan 28, 2026, 12:12 PM EST - Market open

XTL Biopharmaceuticals Revenue

XTL Biopharmaceuticals had revenue of $258.50K in the quarter ending June 30, 2025. This brings the company's revenue in the last twelve months to $968.00K. In the year 2024, XTL Biopharmaceuticals had annual revenue of $451.00K.

Revenue (ttm)
$968.00K
Revenue Growth
n/a
P/S Ratio
8.81
Revenue / Employee
$96,800
Employees
10
Market Cap
8.53M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024451.00K--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro
Jan 1, 2019 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Evogene8.02M
Immuron4.78M
SeaStar Medical Holding881.00K
BioRestorative Therapies383.40K
Pulmatrix3.00K
Ernexa Therapeutics1,000.00
Revenue Rankings